Effect of hepatitis g virus infection on progression of HIV infection in patients with hemophilia

Annals of Internal Medicine

Volumn 132, Issue 12, 2000, Pages 959-963

  Yeo, Anthony E T ^b   Matsumoto, Akihiro ^c   Hisada, Michie ^a   Shih, James W ^b   Alter, Harvey J ^b   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMOPHILIA; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SURVIVAL RATE; VIREMIA; VIRUS HEPATITIS; VIRUS LOAD;

EID: 0034691252     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-12-200006200-00006     Document Type: Article

References (20)

1. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8.
2. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 1997;336:747-54.
3. Zanetti AR, Tanzi E, Romano L, Principi N, Zuin G, Minola E, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Pennatal Hepatitis Viruses Transmission. J Med Virol. 1998;54:107-12.
4. Wu JC, Sheng WY, Huang YH, Hwang SJ, Lee SD. Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol. 1997;52: 83-5.
5. Yeo AE, Matsumoto A, Shih JW, After HJ, Goedert JJ. Prevalence of hepatitis G virus in patients with hemophilia and their steady female sexual partners. Sex Transm Dis. 2000;27:178-82.
6. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion. 1997;37:569-72.
7. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17:209-13.
8. Sabin CA, Devereux H, Kinson Z, Griffioen A, Brown D, Dusheiko G, et al. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19: 546-8.
9. Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis. 1999;179: 783-9.
10. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC 2d, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989;321:1141-8.
11. O'Brien TR, Blattner WA, Waters D, Eyster E, Hilgartner MW, Cohen AR, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA. 1996;276:105-10.
12. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study. Multicenter AIDS Cohort Study. Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 1996;273:1856-62.
13. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ. Viral load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. J Infect Dis. 2000;181:1475-8.
14. Rosenberg PS, Gail MH, Schrager LK, Vermund SH, Creagh-Kirk T, Andrews EB, et al. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. J Acquir Immune Defic Syndr. 1991;4:392-401.
15. Rabkin CS, Hatzakis A, Griffiths PD, Pillay D, Ragni MV, Hilgartner MW, et al. Cytomegalovirus infection and risk of AIDS in human immuno-deficiency virus-infected hemophilia patients. National Cancer Institute Multi-center Hemophilia Cohort Study Group. J Infect Dis 1993;168:1260-3.
16. Kovacs A, Schluchter M, Easley K, Demmler G, Shearer W, La Russa P, et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 1999;341:77-84.
17. Goedert JJ, Steinmeyer LA, Nakatsuji Y. Hepatitis G infection. N Engl J Med. 1997;337:277.
18. Mellor J, Haydon G, Blair C, Livingstone W, Simmonds P. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol. 1998;79(Pt 4):705-14.
19. Woitas RP, Rockstroh JK, Beier I, Jung G, Kochan B, Matz B, et al. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/ hepatitis C virus-coinfected patients. AIDS 1999;13:1313-22.
20. O'Brien TR, Goedert JJ. Chemokine receptors and genetic variability: another leap in HIV research. JAMA. 1998;279:317-8.